MARKET WIRE NEWS
  1. Home
  2. Stock
  3. SEPN
  4. News
SEPN
Quote
Short
News
Articles
Message Board

Septerna Inc. (NASDAQ : SEPN ) News

Septerna Inc. (NASDAQ: SEPN) News Releases

SEPN News Releases
SEPN : NASDAQ
SeekingAlpha
Septerna, Inc. GAAP EPS of -$0.24 beats by $0.02, revenue of $24.1M beats by $8.54M
SEPN : NASDAQ
GlobeNewswire
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
SEPN : NASDAQ
GlobeNewswire
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy
SEPN : NASDAQ
SeekingAlpha
SEP-631 Phase 1 Readout: The Catalyst Set To Drive Septerna In 2026
SEPN : NASDAQ
GlobeNewswire
Septerna to Present at TD Cowen 46th Annual Health Care Conference
SEPN : NASDAQ
SeekingAlpha
The top-performing pharma and biotech stocks as group sees resurgence
SEPN : NASDAQ
GlobeNewswire
Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SEPN : NASDAQ
GlobeNewswire
Septerna to Present Data from Phase 1 Clinical Trial of SEP-631 for the Treatment of Mast Cell-Driven Diseases at 2026 AAAAI Annual Meeting
SEPN : NASDAQ
SeekingAlpha
MRNA is S&P 500's top performing stock, here are the best Quant pharma companies
SEPN : NASDAQ
GlobeNewswire
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.